ArticleBiomedicines2022

Targeting TKI-Activated NFKB2-MIF/CXCLs-CXCR2 Signaling Pathways in FLT3 Mutated Acute Myeloid Leukemia Reduced Blast Viability.

Huynh Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.